METHODS FOR SCREENING AND USING CRISPR/CAS9 GUIDANCE RNA SEQUENCE FROM HIV PROVIRUS GENOME

METHODS FOR SCREENING AND USING CRISPR/CAS9 GUIDANCE RNA SEQUENCE FROM HIV PROVIRUS GENOME

The invention pertains to compositions and methods for identifying gRNAs that are effective in treating a latent HIV infection. An embodiment of the invention provides a cell having incorporated into its genome: a gene that expresses a CRISPR-Cas protein and an HIV pseudovirus genome, wherein the HI...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: The Florida International University Board of Trus tees
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator The Florida International University Board of Trus tees
description The invention pertains to compositions and methods for identifying gRNAs that are effective in treating a latent HIV infection. An embodiment of the invention provides a cell having incorporated into its genome: a gene that expresses a CRISPR-Cas protein and an HIV pseudovirus genome, wherein the HIV pseudovirus genome has a first marker gene encoding a first marker protein under the control of HIV-1 LTR promoter and a second marker gene inserted into the nef gene of the HIV pseudovirus and encoding a second marker protein under the control of a constitutive promoter. Screening methods for identifying gRNAs that can treat a latent HIV infection are also provided. Further, compositions comprising a CRISPR-Cas protein and gRNAs that can treat a latent HIV infection are provided. Furthermore, a method for treating a latent HIV infection in a subject by administering the compositions of CRISPR-Cas protein and gRNAs are described.
format Patent
fullrecord <record><control><sourceid>uspatents_EFI</sourceid><recordid>TN_cdi_uspatents_applications_15449181</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20180251739</sourcerecordid><originalsourceid>FETCH-uspatents_applications_154491813</originalsourceid><addsrcrecordid>eNqNirEKwjAUALs4iPoPb3ITKVawY0hf2gxN6ntNB5cSpEKh1EDq_0vBD3C6O7ht8qixrWzBoCwBS0I02pQgTAGOV5OkuaGzFJxD6XQhjEQgI4Dx7nANRbaGSnfQkO00OYYSja1xn2xeforD4cddclTYyur0icEvw7zE3ocwjU-_jO859uk1y_L0ll7-Hr-ylzeL</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHODS FOR SCREENING AND USING CRISPR/CAS9 GUIDANCE RNA SEQUENCE FROM HIV PROVIRUS GENOME</title><source>USPTO Published Applications</source><creator>The Florida International University Board of Trus tees</creator><creatorcontrib>The Florida International University Board of Trus tees</creatorcontrib><description>The invention pertains to compositions and methods for identifying gRNAs that are effective in treating a latent HIV infection. An embodiment of the invention provides a cell having incorporated into its genome: a gene that expresses a CRISPR-Cas protein and an HIV pseudovirus genome, wherein the HIV pseudovirus genome has a first marker gene encoding a first marker protein under the control of HIV-1 LTR promoter and a second marker gene inserted into the nef gene of the HIV pseudovirus and encoding a second marker protein under the control of a constitutive promoter. Screening methods for identifying gRNAs that can treat a latent HIV infection are also provided. Further, compositions comprising a CRISPR-Cas protein and gRNAs that can treat a latent HIV infection are provided. Furthermore, a method for treating a latent HIV infection in a subject by administering the compositions of CRISPR-Cas protein and gRNAs are described.</description><language>eng</language><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20180251739$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,873,885,64057</link.rule.ids><linktorsrc>$$Uhttps://patentcenter.uspto.gov/applications/15449181$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>The Florida International University Board of Trus tees</creatorcontrib><title>METHODS FOR SCREENING AND USING CRISPR/CAS9 GUIDANCE RNA SEQUENCE FROM HIV PROVIRUS GENOME</title><description>The invention pertains to compositions and methods for identifying gRNAs that are effective in treating a latent HIV infection. An embodiment of the invention provides a cell having incorporated into its genome: a gene that expresses a CRISPR-Cas protein and an HIV pseudovirus genome, wherein the HIV pseudovirus genome has a first marker gene encoding a first marker protein under the control of HIV-1 LTR promoter and a second marker gene inserted into the nef gene of the HIV pseudovirus and encoding a second marker protein under the control of a constitutive promoter. Screening methods for identifying gRNAs that can treat a latent HIV infection are also provided. Further, compositions comprising a CRISPR-Cas protein and gRNAs that can treat a latent HIV infection are provided. Furthermore, a method for treating a latent HIV infection in a subject by administering the compositions of CRISPR-Cas protein and gRNAs are described.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EFI</sourceid><recordid>eNqNirEKwjAUALs4iPoPb3ITKVawY0hf2gxN6ntNB5cSpEKh1EDq_0vBD3C6O7ht8qixrWzBoCwBS0I02pQgTAGOV5OkuaGzFJxD6XQhjEQgI4Dx7nANRbaGSnfQkO00OYYSja1xn2xeforD4cddclTYyur0icEvw7zE3ocwjU-_jO859uk1y_L0ll7-Hr-ylzeL</recordid><startdate>20170303</startdate><enddate>20170303</enddate><creator>The Florida International University Board of Trus tees</creator><scope>EFI</scope></search><sort><creationdate>20170303</creationdate><title>METHODS FOR SCREENING AND USING CRISPR/CAS9 GUIDANCE RNA SEQUENCE FROM HIV PROVIRUS GENOME</title></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_applications_154491813</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>online_resources</toplevel><creatorcontrib>The Florida International University Board of Trus tees</creatorcontrib><collection>USPTO Published Applications</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><aucorp>The Florida International University Board of Trus tees</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHODS FOR SCREENING AND USING CRISPR/CAS9 GUIDANCE RNA SEQUENCE FROM HIV PROVIRUS GENOME</title><date>2017-03-03</date><risdate>2017</risdate><abstract>The invention pertains to compositions and methods for identifying gRNAs that are effective in treating a latent HIV infection. An embodiment of the invention provides a cell having incorporated into its genome: a gene that expresses a CRISPR-Cas protein and an HIV pseudovirus genome, wherein the HIV pseudovirus genome has a first marker gene encoding a first marker protein under the control of HIV-1 LTR promoter and a second marker gene inserted into the nef gene of the HIV pseudovirus and encoding a second marker protein under the control of a constitutive promoter. Screening methods for identifying gRNAs that can treat a latent HIV infection are also provided. Further, compositions comprising a CRISPR-Cas protein and gRNAs that can treat a latent HIV infection are provided. Furthermore, a method for treating a latent HIV infection in a subject by administering the compositions of CRISPR-Cas protein and gRNAs are described.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_applications_15449181
source USPTO Published Applications
title METHODS FOR SCREENING AND USING CRISPR/CAS9 GUIDANCE RNA SEQUENCE FROM HIV PROVIRUS GENOME
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T13%3A25%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFI&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.aucorp=The%20Florida%20International%20University%20Board%20of%20Trus%20tees&rft.date=2017-03-03&rft_id=info:doi/&rft_dat=%3Cuspatents_EFI%3E20180251739%3C/uspatents_EFI%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true